Evidence map›Paper›PMID 42859380›Full record

ReviewInternational urology and nephrology2026

Four cases of type III collagen deposition glomerulopathy and summary of the literature.

Xinyi Lin, Yupeng Xu, Xinti Lin, Yanling Xiong, Yinqiu Lv, Huidi Zhang

Abstract readReview
PubMed Publisher
In one paragraph

Review in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xinyi LinThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yupeng XuThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xinti LinThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yanling XiongThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yinqiu LvThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Huidi ZhangThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. hd_zhang@163.com.

Funding

Natural Science Foundation of Zhejiang Province LMS25H050004
6 · The paper itself

Abstract

Collagen type III glomerulopathy is a rare glomerular disorder characterized by the deposition of type III collagen fibers within the glomeruli, predominantly in the mesangial and subendothelial regions. Renal biopsy with histopathological examination remains the gold standard for diagnosis of this disease. Clinically, collagen type III glomerulopathy typically presents with proteinuria and progressive renal dysfunction, with or without nephrotic syndrome. Collagen type III glomerulopathy affects individuals across all age groups, ranging from children to adults, and shows no apparent sex predominance. This study retrospectively analyzed four patients with collagen type III glomerulopathy diagnosed at the First Affiliated Hospital of Wenzhou Medical University between 2011 and 2024 and reviewed 105 cases reported worldwide in the English-language literature. All patients presented with proteinuria, and half had renal impairment. Electron microscopy consistently demonstrated abnormal collagen fibrils in the mesangial region. Over a median follow-up of 71.5 months, half of the patients with available follow-up data progressed to end-stage renal disease, whereas the remaining patients maintained stable renal function after intervention. Globally, reported collagen type III glomerulopathy cases exhibited heterogeneous clinical presentations, and current data support an association between nephrotic-range proteinuria and poorer renal outcomes.

Indexed as

Clinical manifestationCollagen type III glomerulopathyDiagnostic basisPrognostic analysis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.